In recent years, modafinil, a wakefulness-selling agent initially developed for treating narcolepsy, has gained important reputation as a cognitive enhancer among numerous demographics, notably in city settings. This observational analysis article goals to discover the purchasing behaviors and attitudes surrounding modafinil in London, a metropolis recognized for its various inhabitants
